On this page you can find relevant researchs on drug-related health topics, including HIV, hepatitis C, drug and overdose prevention, harm reduction and drug treatment. You can also find our Clinical Guidelines.

Drugs: International comparators
This International Comparators Study on drugs was conducted by ministers and officials from the Home Office took established to examine national drug policies adopted by a range of countries to tackle drug misuse and dependency.
A therapeutic workplace for the long-term treatment of drug addiction and unemployment: Eight-year outcomes of a social business intervention.
This study evaluated the long-term effects of a therapeutic workplace social business on drug abstinence and employment. This paper reports 4- to 8-year outcomes. During year 4 when a business was open, therapeutic workplace participants provided significantly more cocaine- and opiate-negative urine samples than controls; reported more days employed, higher employment income, and less money spent on drugs.
Persisting pain in children package: WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses
These new WHO guidelines outline basic principles, clinical recommendations and health system recommendations. This brochure highlights selected issues which are essential for, in particular, policy-makers, medicines regulatory authorities, hospital managers and health insurance managers.
Maintenance therapy for injection-drug users associated with lower incidence of hepatitis C
In a group of young users of injection drugs, recent maintenance opioid agonist therapy with methadone or buprenorphine for opioid use disorders, such as heroin addiction, was associated with a lower incidence of hepatitis C virus infection and may be an effective strategy to reduce injection-drug use and the resulting spread of HCV, according to a study.
Opioid-related deaths in Australia
From 2007 to 2009, the number of opioid drug deaths identified on the National Coronial Information System (NCIS) increased by 25.0%. Heroin was the opioid drug most frequently involved in death (particularly in cases of sole drug involvement), with 84.4% of all heroin-related deaths involving males. 87.6% of all heroin related deaths were unintentional in nature.
Current status of drug use and HIV/AIDS prevention in drug users in China
In China, the number of amphetamine-type stimulant users has increased sharply. The strengthening of antiretroviral therapy (ART) treatment for HIV-infected drug users is crucial for HIV/AIDS prevention and control.
DrugLink: October-September 2014
This number of DrugLink covers a lot of health-related topics, such as the arguments in the medical community around prescribing injectable or oral drugs and over private prescribing, drug rehabilitation, HIV and injecting drug use, Hepatitis C, etc.
National HIV league report in Myanmar
This report presents the key findings and recommendation of the review of Myanmar's legal framework and its impact on access to health and HIV prevention and treatment services for people living with HIV and key populations. This review was conducted through a partnership of UNAIDS, UNDP and Pyoe pin in the period August - December 2013, in consultation with the National AIDS programme.
Key findings from the 2014 IDRS: A survey of people who inject drugs
The Illicit Drug Reporting System (IDRS) monitors emerging trends in the use, price, purity and availability of heroin, methamphetamine, cocaine, cannabis and other drugs.
Evidence from the frontline: How policy changes are affecting people experiencing multiple needs
In the UK, 88% of services reported welfare changes had a negative effect on their clients’ overall well-being, and 86% on their mental health. 41% of mental health services said moving the substance misuse budget to public health has had a negative impact.
Share this on: